The use of thymoglobuline induction in renal transplantation: a pharmacovigilance study.
Hurault de Ligny
B
B
Nephrology Department, Clémenceau Hospital, Caen, France.
Lebranchu
Y
Y
D000293:Adolescent; D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000097:blood; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002648:Child; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005260:Female; D005602:France; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D016131:Lymphocyte Subsets / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies
D015703:Antigens, CD; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents